Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 10:29:09 UTC 2023
by
admin
on
Sat Dec 16 10:29:09 UTC 2023
|
| Protein Sub Type | |
| Sequence Type | REPRESENTIVE |
| Record UNII |
WF082S23P7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
WF082S23P7
Created by
admin on Sat Dec 16 10:29:09 UTC 2023 , Edited by admin on Sat Dec 16 10:29:09 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR->RESISTANT TARGET | |||
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR -> TARGET |
NRC-AN-019 treatments were able to reduce leukemia symptoms significantly in both Baf3Wt and Baf3 (T315I) imatinib resistant leukemic mice.
|
||
|
|
INHIBITOR -> TARGET |
nonphosphorylated form
Kd
|
||
|
INHIBITOR -> TARGET | |||
|
INHIBITOR->RESISTANT TARGET | |||
|
|
INHIBITOR -> TARGET | |||
|
INHIBITOR->RESISTANT TARGET | |||
|
INHIBITOR -> TARGET |
IN BA/F3 CELLS PREVENT RESISTANCE
IC50
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|